Artiva Biotherapeutics, Inc. (ARTV) — 8-K Filings
All 8-K filings from Artiva Biotherapeutics, Inc.. Browse 6 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (6)
- 8-K Filing — May 8, 2026
-
Artiva Biotherapeutics Announces Leadership Changes
— Dec 12, 2025 Risk: medium
Artiva Biotherapeutics, Inc. announced on December 10, 2025, changes in its board of directors and executive officers. The filing details the departure of certa -
Artiva Biotherapeutics Files 8-K on Corporate Governance
— Jun 25, 2025 Risk: low
Artiva Biotherapeutics, Inc. filed an 8-K on June 24, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of c -
Artiva Biotherapeutics Announces Board and Compensation Changes
— Jan 29, 2025 Risk: medium
Artiva Biotherapeutics, Inc. announced on January 28, 2025, changes related to its board of directors and executive compensation. Specifically, the company repo -
Artiva Biotherapeutics Files 8-K on Officer/Director Changes
— Oct 22, 2024 Risk: medium
Artiva Biotherapeutics, Inc. filed an 8-K on October 22, 2024, reporting on the departure of directors or certain officers, election of directors, appointment o -
Artiva Biotherapeutics Files 8-K for Bylaw Amendments
— Jul 22, 2024 Risk: low
Artiva Biotherapeutics, Inc. filed an 8-K on July 22, 2024, reporting amendments to its articles of incorporation or bylaws and financial statements. The compan
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX